Non-compliance: the Achilles' heel of anti-fracture efficacy

By Seeman E.   Compston J.   Adachi J.   Brandi M.   Cooper C.   Dawson-Hughes B.   Jönsson B.   Pols H.   Cramer J.  

Osteoporosis International, Vol. 18, Iss. 6, 2007-06 ,pp. : 711-719

Springer Publishing Company

Access to resources Recommend Favorite

Sustained vertebral antifracture efficacy of oral anti-osteoporotic therapies in postmenopausal osteoporosis

By Brandi M.-L.  

Current Medical Research and Opinion, Vol. 26, Iss. 11, 2010-11 ,pp. : 2553-2563

Informa Healthcare

Access to resources Recommend Favorite

Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE

By Chesnut Charles H.   Ettinger Mark P.   Miller Paul D.   Baylink David J.   Emkey Ronald   Harris Steven T.   Wasnich Richard D.   Watts Nelson B.   Schimmer Ralph C.   Recker Robert R.  

Current Medical Research and Opinion, Vol. 21, Iss. 3, 2005-03 ,pp. : 391-402

Informa Healthcare

Access to resources Recommend Favorite

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy

By Russell R.   Watts N.   Ebetino F.   Rogers M.  

Osteoporosis International, Vol. 19, Iss. 6, 2008-06 ,pp. : 733-759

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of oral bisphosphonates for preventing hip fracture in disabled patients with neurological diseases: a meta-analysis of randomized controlled trials among the Japanese population

By Iwamoto Jun   Takeda Tsuyoshi   Matsumoto Hideo  

Current Medical Research and Opinion, Vol. 27, Iss. 6, 2011-06 ,pp. : 1141-1148

Informa Healthcare

Access to resources Recommend Favorite